XTalks

FEBRUARY 23, 2022

While we all deserve a treat, those with allergies can often be excluded from satisfying their sweet tooth without planning and forethought. Together, they created a cookie that is free of the Top 8 allergies as well as mustard, sesame and sulfates. Million to Help Parents Fight the Food Allergy Epidemic. Receives $3.5

Allergies 98

Allergies Branding Production Packaging 98

XTalks

FEBRUARY 26, 2024

The class of IgE-mediated food allergies includes 160 foods, with peanuts, milk, eggs, wheat, soy and tree nuts being the most common ones. According to the Centers for Disease Control and Prevention (CDC), almost six percent of people in the US in 2021 had a food allergy. However, the treatment is restricted to peanut allergy.

Allergies 100

Allergies FDA Approval Drugs Protein 100

pharmaphorum

JULY 28, 2022

Sales of Dupixent (dupilumab) rocketed 43% to €1.96 Sanofi recently raised its full-year sales prediction for the product from €10 billion to €13 billion, thanks in part to uptake of the drug in eosinophilic oesophagitis, a new indication that was approved by the FDA in May. Vaccine sales climbed 15% to €1.8

Sales 59

Sales Allergies Vaccination Vaccine 59

pharmaphorum

DECEMBER 29, 2021

It continues to grow strongly with Sanofi reporting a 53% rise in sales to more than $4.1 Sanofi has suggested the drug could become a $10 billion brand at its peak, if its use can be expanded further into areas like chronic obstructive pulmonary disease (COPD), bullous pemphigoid, prurigo nodularis, chronic hives, and allergies.

Sales 111

Sales Dermatology Marketing Allergies 111

XTalks

JANUARY 26, 2023

The US Food and Drug Administration (FDA) has added sesame to its list of major allergens, making it easier for people with sesame allergies to safely consume packaged food without fear of an allergic reaction. Identifying which foods contain sesame is an important step in food safety and health care as an estimated 0.2

Production 52

Production Containment Allergies Packaging 52

XTalks

JANUARY 14, 2021

In fact, the sale of insects is still prohibited in Italy, France, Germany and Spain, among other European countries. A handful of EU countries, including Finland, Belgium and the Netherlands, do already permit the sale of insect-containing products. They are not, however, widely consumed in the west or Europe.

Allergies 97

Allergies Protein Containment Sales 97

pharmaphorum

FEBRUARY 18, 2022

billion in sales from the drug last year, while Roche – which has rights in the US – made $2.1 It’s waiting on the results of trials in additional indications – chronic-inducible urticaria and food allergies – before planning its next steps. Novartis reported $1.4 billion from the drug.

Trials 104

Trials Sales Allergies Drugs 104

pharmaphorum

NOVEMBER 9, 2022

The FDA’s Pulmonary-Allergy Drugs Advisory Committee (PADAC) voted by 16 to one that PT027 should be approved for use in adults. Earlier this year, analysts at Jefferies predicted that the drug could reach $500 million in peak sales if approved with the label sought.

Drugs 59

Drugs Allergies Marketing Trials 59

Druggist

DECEMBER 28, 2020

The Government recently announced the reclassification of fexofenadine 120mg, which will be available as General sale Medication (GSL), sold as branded products – Allevia 120mg tablets. First-generation antihistamines can also be used to help manage allergies. Until now, fexofenadine was a prescription-only medication.

Pharmacy 98

Pharmacy Doctors Doctor Allergies 98

Triage Cancer

NOVEMBER 4, 2021

Medication errors in healthcare facilities include dispensing the wrong drug or the wrong dosage, drug overdoses, and overlooked drug interactions and allergies. Tell your doctors about any medication-related allergies and/or side effects. Tell your doctors and nurses about any medication-related allergies and/or side effects.

Nurses 97

Nurses Doctors Doctor Allergies 97

The Pharma Data

AUGUST 5, 2021

Group sales increase by 12.9 Sales at all divisions increased by a double-digit percentage after adjusting for currency and portfolio effects, and we expect this positive sales momentum to continue in all our businesses. Group sales in the second quarter increased by 12.9 Group sales in the second quarter increased by 12.9

Sales 52

Sales Production Gene Therapy Allergies 52

XTalks

MAY 2, 2024

Some treatments already on the market have grabbed additional approvals in 2024, including Novo Nordisk’s Wegovy (semaglutide) for cardiovascular risk reduction, Dupixent (dupilumab) for eosinophilic esophagitis (EoE) in young children and Xolair (omalizumab) for food allergies. The firm predicts sales of KarXT could reach $2.8

Drugs 52

Drugs FDA Approval Sales Vaccination 52

pharmaphorum

DECEMBER 20, 2021

The new indication helped pushed Novartis’ Xolair sales firmly into blockbuster territory, reaching $1.06 billion in sales from the drug over the same period. billion in the first nine months of the year, despite pressure from increasing competition in the severe asthma category. Partner Roche meanwhile recorded $1.5

Sales 64

Sales Allergies Trials Clinical Development 64

pharmaphorum

NOVEMBER 30, 2022

Working in the allergy and autoimmune space, COUR looks at nanoparticles and allergens – such as peanut and coeliac (which he had experience with whilst at Takeda) – and infuses these into patients as a treatment so that the body accepts it because of the precise combination technology, patients forming a tolerance to the antigen.

Life Science 98

Life Science Pharma Companies Sales Marketing 98

XTalks

JANUARY 17, 2023

While albuterol rescue inhalers are currently used to alleviate symptoms of an asthma attack, they don’t treat underlying inflammation, explained Bradley Chipps, MD, former president of the American College of Allergy, Asthma and Immunology, in a statement issued by AstraZeneca.

FDA Approval 97

FDA Approval Containment Allergies Drugs 97

pharmaphorum

SEPTEMBER 29, 2022

Sales of Dupixent rocketed 43% to around $2 billion in the second quarter, driven by demand in its main atopic dermatitis and severe asthma indications – fuelled by approvals in earlier age groups – as well as smaller add-on indications, such as oesophagitis.

Drugs 69

Drugs Immune Response Allergies Sales 69

pharmaphorum

APRIL 28, 2021

increase in first-quarter sales to €8.59 Top-seller Dupixent (dupilumab) for atopic dermatitis, asthma and rhinosinusitis associated with nasal polyps led the charge once again, growing 46% to top €1 billion in quarterly sales for the first time, with vaccines also contributing with a consensus-beating 5.3% billion (around $10.4

Drugs 52

Drugs Sales Allergies RNA 52

The Pharma Data

JANUARY 3, 2021

We have a particular passion for allergy, dermatology and specialized care, and specialized nutrition. Our presence covers operations in R&D, supply and sales & marketing in Italy, UK, Germany, the Netherlands, Spain, Sweden, Norway and the US. 4, 2021 11:00 UTC.

Dermatology 40

Dermatology Allergies Branding Business Development 40

pharmaphorum

JULY 8, 2021

AZ has data from its large-scale NAVIGATOR trial showing that tezepelumab can significantly reduce asthma attacks in asthmatics with lower eosinophil levels as well, and EvaluatePharma has said it expects tezepelumab to have annual sales potential of $1 billion-plus by 2026 if approved with a broad label.

Drugs 52

Drugs Antibody Sales Trials 52

Druggist

AUGUST 3, 2020

Sale restrictions Like most ‘P’ medicines, Otrivine nasal spray has sale restrictions. Sale restrictions are related to indicated use of the product reflected by its license. Patients who used this product for seven days and requested another supply of the spray will most likely be refused the sale.

Pharmacy 98

Pharmacy Containment Sales Production 98

The Pharma Data

MAY 18, 2021

Our Crop Science Division achieved encouraging sales growth in an improved market environment. Sales at Pharmaceuticals were steady, and in the Consumer Health Division we performed better than the competition.” Group sales in the first quarter rose by 2.8 Group sales in the first quarter rose by 2.8 EBIT increased by 23.4

Sales 40

Sales Production Marketing Containment 40

pharmaphorum

FEBRUARY 26, 2021

Top-line data were reported last year, but a presentation at the American Academy of Asthma Allergy & Immunology (AAAAI) virtual congress today is the first opportunity for doctors to see the dataset in full.

Trials 69

Trials Allergies Doctors Doctor 69

Druggist

DECEMBER 9, 2020

Sale of some anti-itch creams is restricted to pharmacies only. Eurax cream is a general sale item, which can be purchased in pharmacies and supermarkets. Skin itch is commonly associated with eczema (dermatitis), psoriasis, chickenpox, insect bites, hives and other conditions. Menthol 2% in Aqueous Cream 500g. £24.59. Price incl.

Pharmacy 97

Pharmacy Containment Sales Production 97

pharmaphorum

DECEMBER 9, 2021

Johnson & Johnson Consumer Health focuses its external innovation efforts on Self Care, which consists of allergy, smoking cessation, pain, digestive health, and cough and cold; and Skin Health, which includes acne, sensitive skin, skin protection and aging skin support.

Allergies 105

Allergies Life Science Development Scientist 105

pharmaphorum

OCTOBER 1, 2021

The debut – raising upwards of £350 million from new shares – is the largest IPO for a UK biotech company since allergy drug specialist Circassia in 2014.

Marketing 52

Marketing Business Development Genome Genomics 52

World of DTC Marketing

NOVEMBER 19, 2021

In 2015, the National Institute of Allergy and Infectious Diseases, an institute within the NIH, signed a cooperative R&D agreement with Moderna on basic research, including new vaccines. Additionally, Moderna used patents and non-exclusive rights that the U.S. government made available to them to make this COVID-19 vaccine.

Vaccination 44

Vaccination Vaccine Allergies Production 44

The Pharma Data

NOVEMBER 5, 2020

is a rapidly growing generic pharmaceutical company in the United States devoted to discovery, manufacture, sale, and distribution of prescription generic pharmaceutical products. About Jubilant Cadista Pharmaceuticals Inc. Jubilant Cadista Pharmaceuticals Inc. To learn more about Jubilant Cadista, please visit our website: www.cadista.com.

Marketing 40

Marketing Generic Pharmaceutical Contract Manufacturing Manufacturing 40

Druggist

FEBRUARY 3, 2021

Most supermarkets and pharmacies sell their own ‘brands’ of cetirizine, for example, Tesco Allergy and Hayfever Relief 10mg tablets and Lloyds Pharmacy Antihistamine Hayfever Relief 10mg tablets, both produced by the same manufacturer. 240 - 10mg Loratadine One a Day hay fever and Allergy Relief Tablets GSL - 8 months supply.

Allergies 52

Allergies Pharmacy Containment Branding 52

The Pharma Data

MAY 27, 2022

On Tuesday and Thursday , the FDA also announced steps that will lead to tens of millions of additional bottles of infant formula, including specialty infant formula that is in short supply for infants with certain allergies or critical health conditions.

Production 52

Production Manufacturing Cosmetics Allergies 52

Druggist

JULY 22, 2020

Phenergan Elixir is an oral sedative antihistamine licensed for the management of allergic conditions of the upper respiratory tract including a runny nose, allergies affecting the skin and anaphylactic reactions to drugs and other compounds. Promethazine is used mainly for the management of allergies and as a sleeping aid.

Nurses 52

Nurses Pharmacy Containment Licensing 52

The Pharma Data

MAY 27, 2022

Food and Drug Administration is providing an update on steps it has taken that will lead to millions of bottles of specialized medical infant formula to help address immediate needs for infants with certain allergies or critical health conditions. This type of specialized medical infant formula is currently in short supply in the U.S. “We

Production 52

Production Manufacturing Pharmacy Cosmetics 52

XTalks

DECEMBER 20, 2023

Bayer’s Astepro (azelastine), an over-the-counter medication for cold, flu and allergies, led the pack in the first half of 2023 with 7.4 Notably, pharmaceutical drugs dominated TV ad impressions this year, with an iSpot.tv report indicating that they accounted for half of the most viewed new brands. billion ad impressions.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

The Pharma Data

FEBRUARY 8, 2021

Q4 2020 sales growth (2) of 4.2% Specialty Care sales grew 18.3%, driven by strong Dupixent ® performance (+54.2% Diabetes sales, COVID environment and portfolio streamlining. Diabetes sales, COVID environment and portfolio streamlining. Sales down 2.4% Sales down 2.4% Sales increased 3.3%

Sales 52

Sales Vaccination Vaccine Production 52

The Pharma Data

FEBRUARY 4, 2021

Q4 2020 sales growth (2) of 4.2% Specialty Care sales grew 18.3%, driven by strong Dupixent ® performance (+54.2% Diabetes sales, COVID environment and portfolio streamlining. Diabetes sales, COVID environment and portfolio streamlining. Sales down 2.4% Sales down 2.4% Sales increased 3.3%

Sales 52

Sales Vaccination Vaccine Production 52

pharmaphorum

AUGUST 13, 2020

Bank of America halted foreclosure sales, evictions and repossessions. Here’s a mini roundup: Speed of development and partnership are characteristic of many players, ahead of the race is Moderna (working with the National Institute of Allergy and Infectious Diseases) with a trial under the aptly titled ‘Operation Warp Speed’ now in Phase 3.

Branding 96

Branding Vaccination Vaccine Filler 96

XTalks

AUGUST 2, 2023

Most of the company’s revenue comes from the manufacture and sale of biopharmaceutical products. billion in pharmaceutical sales from 2021. In contrast, several drugs experienced sale declines, such as Remicade (infliximab), an old immunology medication that continues to decline due to the rise of biosimilars since 2016.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

APRIL 27, 2021

Q1 2021 sales increase of 2.4% Specialty Care sales grew 15.3%, due to strong Dupixent ® performance (+45.6% General Medicines core assets grew 4.4%, while GBU sales were down 3.8%. Q1 2021 business EPS ( 1) growth at CER driven by efficiency and sales performance, supported by a one-time payment. IFRS net sales reported.

Sales 52

Sales Vaccination Vaccine Medicine 52